Clinical features and laboratory characteristics of patients hospitalized with COVID-19: single centre report from Egypt.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 12 2020
Historique:
received: 27 05 2020
accepted: 10 09 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 23 1 2021
Statut: epublish

Résumé

The recently discovered novel coronavirus disease (COVID-19) has emerged in Wuhan, China, since January 2020. Egypt reported a low incidence of infection when compared with other countries. The aim of the study was to assess the characterization of COVID-19 infection among the Egyptian population. Data were collected from a single COVID-19 quarantine hospital in Cairo. A total number of 195 cases were included with their clinical, laboratory, and radiological data. Three different age groups behaved differently for COVD-19 infection. The pediatric age group was asymptomatic entirely, the middle age group (18-50 years) were asymptomatic in 53.3% of cases, while 77.9% of those above 50 years were symptomatic (p ≤ 0.001). The latter group had a high incidence of COVID-pneumonia in (83.1%), and moderate to critical presentations were encountered in 66.3% of them. Neutrophil to lymphocyte (N/L) ratio correlated directly with the age and case severity. C-reactive protein (CRP) and computed tomography scan chest (CT-chest) had added value on COVID-19 diagnosis in suspected cases. In Egypt, patients above 50 years are at a higher risk for symptomatic COVID-19 infection and leaner for moderate to critical COVID-19 presentation. The triad of CT-chest, CRP, and N/L ratio could be an integrated panel for assessing disease severity.

Identifiants

pubmed: 33378275
doi: 10.3855/jidc.13156
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1352-1360

Informations de copyright

Copyright (c) 2020 Mohamed El Kassas, Noha Asem, Amr Abdelazeem, Ahmad Madkour, Hamdy Sayed, Ahmed Tawheed, Ahmed Al Shafie, Mahmoud Gamal, Hassan Elsayed, Mohamed Badr, Mohamed Hassany, Dalia Omran, Amr El Fouly.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Mohamed El Kassas (M)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. m_elkassas@hq.helwan.edu.eg.

Noha Asem (N)

Community Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt. noha_asem@yahoo.com.

Amr Abdelazeem (A)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. Dr.amr_abdalazeem@yahoo.com.

Ahmad Madkour (A)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. Doctor.ahmed.madkour@gmail.com.

Hamdy Sayed (H)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. Hamdysayed23@yahoo.com.

Ahmed Tawheed (A)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. Ahmed.tawhid@gmail.com.

Ahmed Al Shafie (A)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. Al.shafie29@gmail.com.

Mahmoud Gamal (M)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. Ma7moudgamal71@gmail.com.

Hassan Elsayed (H)

Microbial Biotechnology Department, National Research Centre, Cairo, Egypt. hassanaboelnor@yahoo.com.

Mohamed Badr (M)

Critical Care Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. drmbadr@hotmail.com.

Mohamed Hassany (M)

Hepatology and Tropical Medicine Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt. mohamadhassany@yahoo.com.

Dalia Omran (D)

Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Daliaomran@kasralainy.edu.eg.

Amr El Fouly (A)

Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt. amrfouly@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH